psoriasis epidemiology forecast insight

DelveInsight’s ‘Psoriasis–Epidemiology Forecast—2034’ report delivers an in-depth understanding of Psoriasis, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5
• Japan

Study Period: 2021-2034

Psoriasis Disease Understanding

Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by papules and plaques occurring most commonly on the elbows, knees, scalp, and lower back, but is not limited to these areas. The World Health Organization recognized psoriasis as a serious non-communicable disease. It has been recognized as skin disease and a systemic disease since it also causes psoriatic arthritis and mental disorders.

Psoriasis has both pediatric and adult-onset, with the former accounting for more number of cases. Plaques vary in terms of variable morphology, distribution and severity. Psoriatic patients are frequently categorized into two groups: mild or moderate to severe psoriasis, depending on the clinical severity of the lesions, the percentage of affected body surface area, and patient quality of life.

There are different clinical types of psoriasis, the most common of which is plaque psoriasis. Less common variants of psoriasis include inverse psoriasis, pustular psoriasis, guttate psoriasis and erythrodermic psoriasis. 

Psoriasis Epidemiology

The Psoriasis epidemiology division provides insights into the historical and current patient pool and the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends and assumptions.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Psoriasis epidemiology segmented as the Prevalent cases of Psoriasis in Pediatrics, Prevalent cases of Psoriasis in Adults, Type-specific prevalent case of Psoriasis, Location-specific prevalent cases of Psoriasis and Severity-specific Prevalent cases of Psoriasis. The report includes the prevalent psoriasis symptoms in 7MM covering the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2021 to 2034.

Country-wise Psoriasis Epidemiology

The epidemiology segment also provides the Psoriasis epidemiology data and findings across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

• The total prevalent population of Psoriasis associated in the 7MM was estimated to be was 173,626 in pediatric population and 15,277,086 in adult population in 2020 and expected to increase for the study period, i.e., 2021-2034.
• As per the estimates, the Adult population has the highest prevalent population of Psoriasis
• Among the types of Psoriasis, Plaque psoriasis is the most common type of psoriasis. It makes up 80– 90% of cases and causes red skin lesions and silver scales anywhere on the body.

Scope of the Report

• Psoriasis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
• Psoriasis Epidemiology Report and Model provide an overview of the risk factors and global trends of Psoriasis in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report provides insight into the historical and forecasted patient pool of Psoriasis in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report helps recognize the growth opportunities in the 7MM concerning the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Psoriasis
• The report provides the segmentation of the Psoriasis epidemiology by Prevalent Cases of Psoriasis in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report provides the segmentation of the Psoriasis epidemiology by severity-specific Prevalent Cases of Psoriasis in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan

Report Highlights

• 10-year Forecast of Psoriasis epidemiology
• United States Coverage
• Total Prevalent Cases of Psoriasis
• Prevalent Cases according to segmentation: Type-specific Prevalence of Psoriasis

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population about Psoriasis?
• What are the key findings of Psoriasis epidemiology across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan and which type will have the highest number of patients during the forecast period (2021-2034)?
• What would be the total number of patients with Psoriasis across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan during the forecast period (2021-2034)?
• At what CAGR the patient population is expected to grow during the forecast period (2021-2034)?
• What are the disease risk, burden, and unmet needs of Psoriasis?
• What are the currently available treatments for Psoriasis?

Reasons to buy

The Psoriasis Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Psoriasis market
• Quantify patient populations in the global Psoriasis market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Psoriasis therapeutics in each of the markets covered
• Understand the magnitude of Psoriasis population by its Prevalence cases
• Understand the magnitude of Psoriasis population by its Type-specific cases
• The Psoriasis epidemiology report and model was written and developed by Masters and PhD level epidemiologists
• The Psoriasis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population